CME/CPD Information

For inquiries regarding CME certificates, please contact Oscar Reyes at The University of Miami.
oreyes@med.miami.edu

Target Audience

The program should appeal to basic scientists and clinicians in the fields of neurology, physical medicine and rehabilitation, ophthalmology, otolaryngology, urology, dermatology, gastroenterology, and pain management.

Learning Objectives

  • Recognize the various serotypes, mechanism of action, potential immunogenicity and pharmacology of botulinum neurotoxin agents to understand their clinical effect
  • Evaluate clinical data, guidance and clinical experience in the use of botulinum neurotoxin for multiple clinical conditions, in order to identify and assess appropriate patients for treatment
  • Demonstrate protocols and techniques for neurotoxin injections, to improve clinical skills and optimize patient outcomes
  • Identify the newest research, both scientific and clinical, that will advance knowledge about the clinical utility of neurotoxins
  • Foster communication and collaboration among a broad range of scientific, academic, and clinical disciplines, to accelerate research and education relevant to neurotoxin use

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Miami Miller School of Medicine and International Neurotoxins Association (INA). The University of Miami Miller School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The University of Miami Miller School of Medicine designates this educational activity for a maximum of 17.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credits commensurate with the extent of their participation in the activity.

Disclosure and Conflict of Interest Resolution

All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to the learners.

Services for the Disabled

If special arrangements are required for an individual with a disability to attend this conference, contact Christina Gallo at cme@neurotoxins.org at least 15 days prior to the conference.

Or call 212-796-0132

cme-page-ina-website